RPG Life Sciences
Ticker >

RPG Life Sciences share price

RPG Life Sciences Ltd.

NSE: RPGLIFE BSE: 532983 SECTOR: Pharmaceuticals & Drugs  37k   197   17

1490.70
-23.15 (-1.53%)
BSE: 19 Apr 04:01 PM

Price Summary

Today's High

₹ 1512

Today's Low

₹ 1481.3

52 Week High

₹ 1740

52 Week Low

₹ 745

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2465.47 Cr.

Enterprise Value

₹ 2408.44 Cr.

No. of Shares

1.65 Cr.

P/E

29.08

P/B

6.81

Face Value

₹ 8

Div. Yield

0.81 %

Book Value (TTM)

₹  219

CASH

₹ 57.04 Cr.

DEBT

₹ 0.01 Cr.

Promoter Holding

72.81 %

EPS (TTM)

₹  51.25

Sales Growth

16.51%

ROE

24.01 %

ROCE

32.92%

Profit Growth

31.39 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of RPG Life Sciences Ltd.

Lomotil Lomofen Naprosyn Azoran Aldactone and Serenace Minmin Tonic Romilast Tricaine Sildura

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year16.51%
3 Year10.94%
5 Year8.32%

Profit Growth

1 Year31.39%
3 Year32.6%
5 Year38.13%

ROE%

1 Year24.01%
3 Year22.06%
5 Year18.05%

ROCE %

1 Year32.92%
3 Year30.55%
5 Year24.36%

Debt/Equity

0

Price to Cash Flow

27.15

Interest Cover Ratio

80.7217391304348

CFO/PAT (5 Yr. Avg.)

1.55720317683724

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 72.81 0
Sep 2023 72.81 0
Jun 2023 72.81 0
Mar 2023 72.81 0
Dec 2022 72.61 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 32.6025747017839% for the Past 3 years.
  • The company has significantly decreased its debt by 0.57 Cr.
  • Company has been maintaining healthy ROE of 22.0570777204191% over the past 3 years.
  • Company has been maintaining healthy ROCE of 30.5487736465945% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 80.7217391304348.
  • Company’s PEG ratio is 0.926517895528825.
  • The company has an efficient Cash Conversion Cycle of -46.646796984815 days.
  • Company has a healthy liquidity position with current ratio of 2.56907958746838.
  • The company has a good cash flow management; CFO/PAT stands at 1.55720317683724.
  • The company has a high promoter holding of 72.81%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 5.1784422873579.

 Limitations

  • The company has shown a poor revenue growth of 10.9399790594978% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 130.6 118.49 147.78 153.58 153.7
Total Expenditure 101.39 102.58 115.54 116.29 115.8
Operating Profit 29.21 15.91 32.24 37.29 37.9
Other Income 0.51 1.84 1.81 1.83 1.92
Interest 0.07 0.05 0.07 0.1 0.14
Depreciation 3.91 3.89 4.21 4.23 4.14
Exceptional Items 0 0 0 0 0
Profit Before Tax 25.74 13.81 29.77 34.79 35.54
Tax 6.63 3.46 7.67 8.93 9.08
Profit After Tax 19.11 10.35 22.1 25.86 26.46
Adjusted EPS (Rs) 11.56 6.26 13.36 15.64 16

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 330.16 375.57 389.14 440.16 512.81
Total Expenditure 295.73 315.67 318.37 353 409.29
Operating Profit 34.43 59.9 70.77 87.16 103.52
Other Income 0.8 0.99 1.07 3.08 4.8
Interest 4.86 2.76 1.79 1.41 1.15
Depreciation 15.32 16.36 16.47 15.66 15.49
Exceptional Items 0 -5.32 0 0 0
Profit Before Tax 15.05 36.45 53.58 73.17 91.68
Tax 4.24 7.44 13.58 21.69 24.04
Net Profit 10.81 29.01 40 51.48 67.64
Adjusted EPS (Rs.) 6.54 17.54 24.19 31.13 40.9

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 13.23 13.23 13.23 13.23 13.23
Total Reserves 147.27 163.34 203.22 242.54 294.37
Borrowings 6.58 1.52 0.74 0.3 0
Other N/C liabilities 3 7.23 6.45 8.43 8.97
Current liabilities 77.82 82.59 79.69 80.11 102.78
Total Liabilities 247.9 267.91 303.33 344.61 419.35
Assets
Net Block 127.64 122.89 113.3 103.71 124.26
Capital WIP 10.12 7.28 9.44 25.45 15.03
Intangible WIP 7.05 2.7 2.33 5.61 10.41
Investments 0 0 0 0 0
Loans & Advances 6 9.26 2.41 2.93 5.6
Other N/C Assets 0 0 0 0 0
Current Assets 97.09 125.78 175.85 206.91 264.05
Total Assets 247.9 267.91 303.33 344.61 419.35
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 15.05 36.45 53.58 73.17 91.68
Adjustment 20.08 22.52 16.55 13.54 13.31
Changes in Assets & Liabilities 14.37 -2.37 -3.53 -3.11 11.05
Tax Paid -3.72 -6.43 -8.33 -18.85 -25.22
Operating Cash Flow 45.78 50.17 58.27 64.75 90.82
Investing Cash Flow -19.02 -10.7 -7.96 -34.66 -105.81
Financing Cash Flow -26.5 -39.3 -10.49 -13.51 -17.12
Net Cash Flow 0.26 0.17 39.82 16.58 -32.11

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 72.61 72.81 72.81 72.81 72.81
carniwal investments ltd 0.04 0.04 0.04 0.04 0.04
ektara enterprises llp 15.57 15.57 15.57 15.57 15.57
harsh vardhan goenka 0.16 0.16 0.16 0.16 0.16
mala goenka 0.05 0.05 0.05 0.05 0.05
nucleus life trust (mr. h... 53.60 53.80 53.80 53.80 53.80
stel holdings limited 3.18 3.18 3.18 3.18 3.18
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 27.39 27.19 27.19 27.19 27.19
authum investment and inf... 2.01 2.01 2.01 2.02 2.02
llp 0.08 0.05 0.07 0.07 0.08
mirae asset multicap fund... - - - - 1.08
investor education and pr... 0.99 - 1.02 1.03 -
investor education and pr... - 0.99 - - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • ConcallQ2FY24 30 Oct 2023
  • PresentationQ4FY23 19 Jun 2023
  • PresentationQ4FY22 6 May 2022
  • PresentationQ4FY21 15 Jun 2021
  • PresentationQ3FY24 5 Feb 2024
  • PresentationQ2FY24 20 Oct 2023
  • PresentationQ1FY23 29 Sep 2022

Company News

RPG Life Sciences signs Share Subscription, Shareholders' agreement with Sunpound12 Mar 2024, 5:40PM RPG Life Sciences - Quaterly Results1 Feb 2024, 5:49PM RPG Life Sciences - Quaterly Results1 Feb 2024, 5:49PM RPG Life Sciences - Quaterly Results1 Feb 2024, 5:49PM RPG Life Sciences informs about details of loss of certificate20 Dec 2023, 4:36PM RPG Life Sciences informs about investor presentation 19 Oct 2023, 5:09PM RPG Life Sciences to execute power delivery agreement with Sunpound19 Oct 2023, 11:51AM RPG Life Sciences - Quaterly Results18 Oct 2023, 6:23PM RPG Life Sciences - Quaterly Results18 Oct 2023, 6:23PM Rpg Life Sciences informs about loss of share certificate16 Oct 2023, 4:51PM RPG Life Sciences informs about certificate11 Oct 2023, 3:53PM Rpg Life Sciences informs about press release29 Jul 2023, 2:59PM RPG Life Sciences - Quaterly Results28 Jul 2023, 5:50PM RPG Life Sciences - Quaterly Results28 Jul 2023, 5:50PM RPG Life Sciences - Quaterly Results28 Jul 2023, 5:50PM RPG Life Sciences informs about transcript of earnings call8 May 2023, 11:18AM RPG Life Sciences - Quaterly Results28 Apr 2023, 6:54PM RPG Life Sciences - Quaterly Results28 Apr 2023, 6:54PM RPG Life Sciences - Quaterly Results1 Feb 2023, 5:33PM RPG Life Sciences - Quaterly Results1 Feb 2023, 5:33PM RPG Life Sciences - Quaterly Results1 Feb 2023, 5:33PM RPG Life Sciences - Quaterly Results17 Oct 2022, 6:43PM RPG Life Sciences - Quaterly Results17 Oct 2022, 6:43PM RPG Life Sciences - Quaterly Results17 Oct 2022, 6:43PM RPG Life Sciences - Quaterly Results2 Aug 2022, 6:17PM RPG Life Sciences - Quaterly Results2 Aug 2022, 6:17PM RPG Life Sciences - Quaterly Results29 Apr 2022, 6:21PM RPG Life Sciences informs about newspaper publications27 Jan 2022, 4:52PM RPG Life Sciences informs about loss of share certificate24 Nov 2021, 4:33PM RPG Life Sciences informs about loss of share certificate18 Oct 2021, 12:21PM RPG Life Sciences informs about loss of share certificate11 Oct 2021, 10:59AM RPG Life Sciences informs about newspaper publication10 Aug 2021, 4:37PM RPG Life Sciences informs about details of loss of share certificate31 Jul 2021, 1:17PM RPG Life Sciences informs about investor presentation26 Jun 2021, 12:51PM RPG Life Sciences informs loss of share certificate27 May 2021, 3:49PM RPG Life Sciences reply to clarification sought by exchanges for increase in volume22 Apr 2021, 3:55PM RPG Life Sciences informs about newspaper publications27 Jan 2021, 3:22PM RPG Life Sciences, Seniority launches ‘SafeSeniors’ risk monitoring tool for senior citizens7 Apr 2020, 12:52PM

RPG Life Sciences Stock Price Analysis and Quick Research Report. Is RPG Life Sciences an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into RPG Life Sciences and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. RPG Life Sciences cash from the operating activity was Rs 90.82 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. RPG Life Sciences has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In RPG Life Sciences , the EPS growth was 31.3906833754694 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, RPG Life Sciences has OPM of 20.1868138296835 % which is a good sign for profitability.
     
  • ROE: RPG Life Sciences have a healthy ROE of 24.0126382306477 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of RPG Life Sciences is Rs 1491.5. One can use valuation calculators of ticker to know if RPG Life Sciences share price is undervalued or overvalued.
Last Updated on:
Brief about RPG Life Sciences

RPG Life Sciences Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

RPG Life Sciences Ltd. is a leading pharmaceutical company specializing in the manufacturing and marketing of quality pharmaceutical products. With a rich history spanning several decades, RPG Life Sciences has become a trusted name in the healthcare industry. The company is committed to delivering innovative and affordable medicines to improve the quality of life for patients across the globe.

RPG Life Sciences Ltd. Share Price

Stay up-to-date with RPG Life Sciences Ltd.'s share price and track its performance in the stock market. Our website provides real-time and historical share price data, enabling investors to make informed decisions. Our pre-built screening tools allow you to analyze RPG Life Sciences Ltd.'s share price, helping you identify trends and patterns.

RPG Life Sciences Ltd. Balance Sheet

The balance sheet is an essential financial statement that provides a snapshot of RPG Life Sciences Ltd.'s financial position at a given point in time. By examining the company's assets, liabilities, and equity, investors can assess its financial stability and solvency. Our website offers access to RPG Life Sciences Ltd.'s balance sheet as a downloadable document. Take advantage of our premium features, such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, to perform a thorough evaluation of the balance sheet.

RPG Life Sciences Ltd. Annual Report

The annual report is a comprehensive document that provides insights into RPG Life Sciences Ltd.'s performance, strategies, and future prospects. It includes information on the company's financials, business operations, milestones, and achievements. At our website, you can easily download RPG Life Sciences Ltd.'s annual report, enabling you to dive deeper into the company's performance and outlook.

RPG Life Sciences Ltd. Dividend

RPG Life Sciences Ltd. is committed to creating value for its shareholders. One way the company rewards its shareholders is through dividends. Dividends provide investors with a portion of the company's profits. Stay updated on RPG Life Sciences Ltd.'s dividend history and declared dividends on our website. Analyze the company's dividend payment pattern and evaluate its potential as an income-generating investment.

RPG Life Sciences Ltd. Quarterly Result

Track RPG Life Sciences Ltd.'s quarterly performance and stay informed about the company's financial results. Our website offers access to RPG Life Sciences Ltd.'s quarterly reports as downloadable documents. Combine the quarterly results with our premium features, such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, to gain a comprehensive understanding of the company's financials and performance trends.

RPG Life Sciences Ltd. Stock Price

Stay connected to the latest stock price movements of RPG Life Sciences Ltd. Our website provides real-time updates on the stock's performance, helping you make informed investment decisions. Utilize RPG Life Sciences Ltd.'s stock price chart to identify price trends and patterns. Our pre-built screening tools offer additional insights into RPG Life Sciences Ltd.'s stock price, empowering you to conduct a thorough analysis.

RPG Life Sciences Ltd. News

Keep yourself updated with the latest news and developments related to RPG Life Sciences Ltd. Our website provides a dedicated news section, aggregating news articles and press releases relevant to the company. Stay informed about market trends, regulatory changes, product launches, partnerships, and more. Access to reliable and relevant news can help you make informed investment decisions.

RPG Life Sciences Ltd. Concall Transcripts

Eager to gain insights directly from RPG Life Sciences Ltd.'s management team? Our website offers downloadable concall transcripts, allowing you to access firsthand information shared during the company's conference calls. By reviewing the concall transcripts, investors can gain a deeper understanding of RPG Life Sciences Ltd.'s strategies, performance updates, and future prospects.

RPG Life Sciences Ltd. Investor Presentations

Our website provides downloadable investor presentations by RPG Life Sciences Ltd. These presentations offer valuable insights into the company's business model, growth strategies, financial performance, and objectives. The presentations are an excellent resource for investors looking to understand RPG Life Sciences Ltd.'s value proposition and investment potential.

RPG Life Sciences Ltd. Promoters

The promoters of RPG Life Sciences Ltd. play a crucial role in the company's success. Our website provides detailed information about the promoters and their contributions to the company's growth. Understanding the promoters' background, experience, and vision can provide investors with valuable insights and help them evaluate the company's long-term prospects.

RPG Life Sciences Ltd. Shareholders

Explore RPG Life Sciences Ltd.'s shareholder base and understand the company's ownership structure. Our website offers insights into the major shareholders of RPG Life Sciences Ltd., providing information about institutional investors, mutual funds, and individual investors holding significant positions in the company. Understanding the shareholder base can help investors assess the confidence and support the company enjoys from the market.

By providing comprehensive stock analysis resources like company profiles, share prices, balance sheets, annual reports, dividends, quarterly results, stock prices, price charts, news, concall transcripts, investor presentations, promoters, and shareholders, our website strives to empower long-term stock investors looking for in-depth analysis. Additionally, our premium features, such as fair value calculation tools like DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, offer advanced insights to support your investment decisions. Access these resources and tools on our website to gain a comprehensive understanding of RPG Life Sciences Ltd.'s stock and make informed investment choices.

Read More
X